Osteoporosis prevention among chronic glucocorticoid users: results from a public health insurance database

INTRODUCTION: Long-term glucocorticoid therapy is the leading cause of secondary osteoporosis. The management of glucocorticoid-induced osteoporosis (GIOP) seems to be inadequate in many European countries. OBJECTIVE: To evaluate the rate of screening and treatment of GIOP. DESIGN: Information was c...

Descripción completa

Detalles Bibliográficos
Autores principales: Trijau, Sophie, de Lamotte, Gaëlle, Pradel, Vincent, Natali, François, Allaria-Lapierre, Véronique, Coudert, Hervé, Pham, Thao, Sciortino, Vincent, Lafforgue, Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Osteoporosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4947732/
https://www.ncbi.nlm.nih.gov/pubmed/27486526
http://dx.doi.org/10.1136/rmdopen-2016-000249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4947732/
https://www.ncbi.nlm.nih.gov/pubmed/27486526
http://dx.doi.org/10.1136/rmdopen-2016-000249

Ejemplares similares